Encompass Health CORP Form 4 insider transactions

Director Kevin J. O'Connor reports the acquisition of 14 restricted stock units of Encompass Health Corp due to a dividend payment.

Director Patricia Anne Maryland acquired 24 restricted stock units of Encompass Health Corp due to a dividend payment on October 15, 2024.

Leslye G. Katz, a director of Encompass Health Corp, acquired 81 shares of common stock through a dividend reinvestment program on October 15, 2024.

Director Joan E. Herman reports acquiring 81 restricted stock units of Encompass Health Corp due to a dividend payment.

Director Edward M. Christie III reports acquisition of Encompass Health Corp shares through dividend reinvestment and deferred stock investment plan.

Director Greg D. Carmichael reports dividend reinvestments and restricted stock unit awards, increasing his holdings in Encompass Health common stock.

Encompass Health's EVP & CFO, Douglas Coltharp, exercised stock options and sold shares on August 13, 2024, according to a Form 4 filing with the SEC.

Terrance Williams, a director at Encompass Health Corp, acquired 24 shares of common stock due to a dividend reinvestment program.

Director Nancy M. Schlichting reports acquiring 35 shares of Encompass Health Corp through dividend reinvestment on July 15, 2024.

Christopher R. Reidy, a director at Encompass Health Corp, increased his holdings through dividend reinvestments and participation in the Directors Deferred Stock Investment Plan.

Director Kevin J. O'Connor acquired 13 shares of Encompass Health Corp through dividend reinvestment on July 15, 2024.

Patricia Anne Maryland, a director at Encompass Health Corp, acquired 24 restricted stock units (RSUs) due to a dividend payment on July 15, 2024.

Leslye G. Katz, a director of Encompass Health Corp, reported acquiring 80 shares of common stock due to a dividend reinvestment program.

Director Joan E. Herman reports the acquisition of 80 restricted stock units (RSUs) of Encompass Health Corp due to dividend payments.

Director Edward M. Christie III increases his holdings in Encompass Health through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.

Greg D. Carmichael, a director at Encompass Health Corp, acquired 24 shares of common stock due to a dividend reinvestment program.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, sold 10,000 shares of common stock at an average price of $85.02 on May 24, 2024.

Encompass Health's EVP, General Counsel & Secretary, John Patrick Darby, exercised stock options and sold shares on May 6, 2024.

Director Greg D. Carmichael of Encompass Health Corp (EHC) recently acquired 2,000 shares of company stock at a price of $83.73 per share.

Director Terrance Williams reports acquiring 1,978 shares of Encompass Health Corp stock through an annual grant of restricted stock units.

Director Nancy M. Schlichting reports acquiring 1,978 shares of Encompass Health Corp restricted stock units on May 2, 2024, as part of an annual grant.

Christopher R. Reidy, a director of Encompass Health Corp, reported the acquisition of 1,978 restricted stock units on May 2, 2024.

Director Kevin J. O'Connor reports acquisition of 1,978 shares of Encompass Health Corp restricted stock units.

Patricia Anne Maryland, a director of Encompass Health Corp, reported acquiring 1,978 shares of common stock on May 2, 2024, as part of an annual grant of restricted stock units.

Director Leslye G. Katz reports acquiring 1,978 shares of Encompass Health Corp through a restricted stock unit grant.

Director Joan E. Herman reports acquiring 1,978 shares of Encompass Health Corp common stock on May 2, 2024, through an annual grant of restricted stock units.

Director Edward M. Christie III acquired 1,978 shares of Encompass Health Corp through a restricted stock unit grant.

Director Greg D. Carmichael reports acquiring 1,978 shares of Encompass Health Corp stock on May 2, 2024, through an annual grant of restricted stock units.

Encompass Health's CEO, Mark Tarr, exercised stock options and sold shares on April 30, 2024, according to a recent SEC filing.

Director Edward M. Christie III increases his holdings in Encompass Health through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.